Diana Al Delbany
Brussels, BRU 1090, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Atypical Chemokine Receptor CCRL2 Shapes Tumor Spheroid Structure and Immune Signaling in Melanoma.
Journal: Biomolecules
Published: May 31, 2025
1q gain bypasses the selective barrier against aneuploidy in RPE differentiation via wild-type co-culture rescue.
Journal: Nature communications
Published: September 13, 2024
De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.
Journal: Cells
Published: July 04, 2024
Gain of 1q confers an MDM4-driven growth advantage to undifferentiated and differentiating hESC while altering their differentiation capacity.
Journal: Cell death & disease
Published: November 06, 2023
SALL3 mediates the loss of neuroectodermal differentiation potential in human embryonic stem cells with chromosome 18q loss.
Journal: Stem cell reports
Published: September 28, 2023
Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis.
Journal: Cancers
Published: August 19, 2021
Corrigendum: Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis.
Journal: Frontiers in oncology
Published: May 15, 2020
Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis.
Journal: Frontiers in oncology
Published: July 18, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026